Block Grant R36DP001166

This $129,708 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will support a 5-year study at Purdue University to examine the impact of local tobacco retail policies on sociodemographic disparities in tobacco use outcomes. The key objectives of the study are to: 1) Describe and examine the impact of local tobacco retailer licensing laws and fees on differences in retailer density by race/ethnicity, income, and education; 2) Measure the...

This federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research program) provides $694,771 to the Regents of the University of Minnesota to evaluate population-based strategies for improving smoking cessation rates among rural populations. The key objectives are to determine the efficacy of providing rural people who smoke with a free nicotine replacement therapy (NRT) starter kit and digital...

This is a $740,533 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), to evaluate the effectiveness of providing e-cigarettes with or without behavioral support ("Switch It") for switching chronic smokers with mental illness from combustible cigarettes to e-cigarettes. The study aims to assess whether the addition of the "Switch It" behavioral support intervention can improve harm...

This $282,298 Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research on the impact of social-contextual stressors on smoking cessation and relapse among socioeconomically disadvantaged young adults (SDYA) who smoke cigarettes. The award, granted to Brown University, aims to provide empirical evidence on the social-contextual predictors of smoking cessation in this high-risk population. The research approach...

The National Cancer Institute (NCI) awarded a $395,051 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to Rutgers, The State University of New Jersey to evaluate the implementation and short-term impact of a new New Jersey law requiring tobacco retailers to sell nicotine replacement therapy (NRT). The project aims to: Determine if NRT compliance varies by neighborhood characteristics using store audits and spatial analyses examining the relationship between compliance and...

This Cooperative Agreement award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides $639,964 to the University of Wisconsin System to conduct a pragmatic research study to evaluate implementation strategies for promoting smoking cessation treatment referrals among socioeconomically disadvantaged clients served by the Salvation Army. The project aims to refine and test two implementation strategies: 1) a collaborative,...

This $667,828 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) seeks to enhance the reach and effectiveness of tobacco quitline services for socioeconomically disadvantaged populations. The project will adapt the evidence-based Ask-Advise-Connect (AAC) model for implementation within community-based food pantry settings, conducting a cluster randomized trial to evaluate the reach and effectiveness of the adapted...

The National Cancer Institute (NCI) awarded a Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) in the amount of $661,139 to The Ohio State University to conduct a 6-year study on the use of oral nicotine pouches (ONPs) as a substitute for cigarette smoking among rural Appalachian adults. The study will randomize 1,000 adult smokers in rural Appalachia to either an ONP or nicotine replacement therapy (NRT) arm, with participants sampling products during a 2-week phase and...

This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), provides $407,581 to Texas Christian University (TCU) to conduct a longitudinal study examining the cognitive mediators and personal/interpersonal moderators of the relationship between social media engagement and electronic nicotine delivery systems (ENDS) use among young adults. The 3-year project will track a nationally representative cohort of 1,000...

The U.S. National Institute on Drug Abuse (NIDA) awarded a $1,218,738 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Oklahoma Health Sciences Center. This 3-year grant, running from August 1, 2024 to March 21, 2025, will fund research to elucidate the impact of minority stress factors on tobacco use among sexual minority young adults (SMYAs), particularly those living in rural areas. The research plan includes a 2-year longitudinal survey...